SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is facing intense volatility and a sharp sell-off following a mixed earnings report where revenue fell slightly short of expectations and Q3 guidance disappointed investors. The community is deeply divided, with bearish voices highlighting a loss of momentum and concerns over high subscription costs, while bullish investors view the price drop as a potential valuation reset for a long-term holding.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

Intuitive Surgical is trending following an earnings beat that outperformed analyst expectations for both revenue and EPS, though the stock has faced volatility due to conservative full-year procedure guidance and broader macroeconomic headwinds. Investors are closely monitoring its long-term growth potential in robotic surgery alongside ongoing community debate regarding its premium valuation versus emerging competition.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet shares are under intense pressure following reports that the Gemini 3.5 Pro model is facing significant development delays, fueling market fears that Google is losing ground to AI rivals. The community is sharply divided, with some investors viewing the sell-off as a temporary panic-driven overreaction in a dominant stock, while others are aggressively rotating into safer assets due to concerns over high AI capital expenditure and execution speed.

Oracle Corporation. The Group's principal activities are to develop, manufacture, market, distribute and service computer software. It has two businesses, software and services, which are further divided into five segments. Its software business consist of two segments: The new software license segment is engaged in the licensing of database, middleware software and applications software.The software license updates and product support segment provides customers with rights to unspecified software product upgrades and maintenance releases, internet access to technical content, internet and telephone access to technical support personnel. Its services business is comprised of three segments: The consulting segment provides services in business strategy and analysis, business process simplification, solutions integration and the implementation, enhancement and upgrade of database, middleware and applications software. On Demand includes Oracle On Demand and Advanced Customer Services.

Oracle Corp.

Oracle is experiencing intense selling pressure as investors grapple with concerns over the company's aggressive debt-fueled capital expenditure plans and the sustainability of its AI infrastructure demand. While some in the community see the recent sharp correction as a long-term accumulation opportunity given the massive enterprise backlog, others remain deeply skeptical, fearing further dilution and questioning whether the stock has truly found a bottom amid the broader market volatility.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is currently in the spotlight as investors analyze strong second-quarter financial results that surpassed expectations and a raised full-year profit outlook. Community sentiment is mixed, with bulls highlighting the company's resilient fundamentals and AI-driven margin improvements, while critics remain vocal about ongoing regulatory scrutiny and rising healthcare costs.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is hitting all-time highs as investors pivot into the tech giant following positive regulatory news regarding the deployment of its AI platform in China. The community is actively debating the stock's valuation and momentum, with many highlighting its role as a stable anchor in a volatile market while others caution against its elevated earnings multiples.

The Charles Schwab Corp. is a savings and loan holding company, which engages in the provision of wealth management, securities brokerage, banking, asset management, custody, and financial advisory services. It operates through the Investor Services and Advisor Services segments. The Investor Services segment includes retail brokerage, investment advisory, and banking and trust services to individual investors, retirement plan and business services, as well as other corporate brokerage services, to businesses and employees. The Advisor Services segment provides custodial, trading, banking and trust, and support services to independent registered investment advisors, independent retirement advisors, and recordkeepers. The company was founded by Charles Robert Schwab in 1986 and is headquartered in Westlake, TX.

Charles Schwab Corp.

Charles Schwab is trending as frustrated users report widespread app outages and system glitches that prevented them from managing positions during market hours. The community is actively discussing the unreliability of the platform compared to competitors and expressing dissatisfaction with the lack of stable service following the integration of Thinkorswim.

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Regenxbio Inc

Regenxbio is under significant downward pressure following the announcement of a Complete Response Letter (CRL) from the FDA for its Hunter syndrome gene therapy, RGX-121, which cited concerns over trial design and the use of surrogate endpoints. The community is actively debating the company's limited cash runway, the potential for future equity dilution, and whether the company's remaining assetsspecifically its Duchenne and wet AMD programscan stabilize the stock despite this regulatory setback.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is experiencing significant volatility as investors debate the impact of hyperscaler competition against the company's recent $1 billion AI deal and shift toward an asset-light partnership model. The community remains deeply divided, with many traders viewing the current pullback as a prime accumulation opportunity while others express caution regarding capital-intensive business risks and broader sector rotation.

Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.

Personalis Inc

Personalis is currently trending as investors weigh strong clinical adoption and recent Medicare coverage milestones against concerns over the timeline for immunotherapy (IO) reimbursement and future capital needs. The community is focused on the potential of the NeXT Personal platform as critical infrastructure for personalized oncology and cancer vaccines, while actively debating the valuation and the long-term impact of its strategic partnership with Tempus AI.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--ACA, APGE, BOLD, and GBCS

SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--ACA, APGE, BOLD, and GBCS SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--ACA, APGE, BOLD, and GBCS PR Newswire NEW YORK, July 2, 2026 NEW YORK, July 2, 2026 /PRNewswire/ -- Class...

Are TECH, APGE, BOLD, REFI Obtaining Fair Deals for their Shareholders?

Are TECH, APGE, BOLD, REFI Obtaining Fair Deals for their Shareholders? Are TECH, APGE, BOLD, REFI Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, June 25, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...

Why Did BOLD, BLZE, QNT Stocks Surge To 52-Week Highs Today 

Equity

Investors showed interest in businesses tied to artificial intelligence infrastructure, advanced biotechnology, and quantum computing.



$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Boundless Bio, Inc. (NASDAQ: BOLD)

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Boundless Bio, Inc. (NASDAQ: BOLD) $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Boundless Bio, Inc. (NASDAQ: BOLD) PR Newswire NEW YORK, June 23, 2026 NEW YORK, June 23, 2026 /PRNewswire...

BOLD Stock Is Up 90% — Here's What's Behind The Biggest Rally In Company History

Boundless Bio is set to merge with Serapha Bio, with the transaction set to close in the fourth quarter of 2026.

BOLD Stock Alert: Halper Sadeh LLC is Investigating Whether Boundless Bio, Inc. is Obtaining a Fair Price for its Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the merger of Boundless Bio, Inc. (NASDAQ: BOLD) and Serapha Bio, Inc. Upon closing of the proposed transaction, Boundless Bio shareholders are expected to own approximately 3.7% of the combined company.Halper Sadeh encourages...

Market Movers Catching Transformational Catalysts

Today’s common theme is scale. Whether through regulatory advancement, access to new capital, expanding commercial opportunities, or technological innovation, companies that successfully execute during periods of rapid change often find themselves at important inflection points. $NTHI, $BOLD, $BLZE, $CRWV, $PLTR, $ZETA, $ATLN, $HSCS

Big Money Backs Base Editing, as BOLD Deal Creates Well-Funded AATD Contender

The biotechnology sector continues to reward companies developing potentially transformative genetic medicines, particularly those addressing serious diseases with limited treatment options. The latest example emerged as Boundless Bio (NASDAQ:BOLD) announced a merger agreement with privately held Serapha Bio, a clinical-stage gene editing company developing an investigational treatment for Alpha-1 Antitrypsin Deficiency (AATD), alongside a substantial $230 million private financing commitment from a syndicate of prominent healthcare investors.

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Gainers

HeartSciences (NASDAQ:HSCS) stock rose 82.2% to $3.23 during Tuesday's pre-market session. The company's market cap stands at $5.6 million.
Boundless Bio (NASDAQ:BOLD) shares rose 62.85% to $2.28. Theread more...

Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034)  DelveInsight

Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight Biliary Tract Cancer Market is Predicted to Exhibit...

Boundless Bio, Inc. is a clinical-stage oncology company, which is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA. The company was founded by Vineet Bafna, Paul Mischel, Benjamin F. Cravatt, and Jonathan E. Lim on April 10, 2018 and is headquartered in La Jolla, CA.

Boundless Bio Inc.

Neutral Sentiment

Memory - $MU, $SNDK, $STX, $SKHY, etc.

Neoclouds - $NBIS, $CRWV, $IREN, $APLD, etc.

Space - $RKLB, $SPCX, $ASTS, $VOYG, etc.

Neoclouds, space, and memory are among the market's most beaten-down sectors over the past week - all trading well off their recent highs despite strong underlying demand. Which are you most interested in buying right now? Explain your reasoning in the comments.

Which beaten-down industry are you most interested in adding exposure to?

Current Price	$2.49
Prev Close	$2.47
Open	$2.47
Dividend Yield	0.00%
50-Day Moving Average	$1.79
Beta	1.22
Avg. Volume	3.39M
PE Ratio	-0.99

52-Week High	$2.79
52-Week Low	$0.9612
Market Capitalization	$55.51M
EPS (Annual)	-$2.60
Price to Book	0.64
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

BOLDBoundless Bio Inc.

Latest BOLD News